Clinical Trial Update: Effect of Atazanavir on Endothelial Function in HIV-Infected Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated the effect of atazanavir on endothelial function in HIV-infected patients with dyslipidemia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• HIV Infection

Drugs mentioned

• REYATAZ (atazanavir)

Snippet

Sponsor: Foundation for Cardiovascular Research, Zurich | Conditions: HIV Infections, Dyslipidemia | Phase 4 | Status: COMPLETED